Or Yat Sun
Chief Scientific Officer at ENTA
- Sold, on record
- $8.5M
- Dollars the filings state
- Form 4 sales
- 19
- Latest Dec 5, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ENTAENANTA PHARMACEUTICALS INCChief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ENTAUnusualNov 29, 2016 2016
Sold 13,921 shares at $31.44 ($438k)
Or Yat Sun, Chief Scientific Officer
Sold 4.2% of holdings ($10.4M position)315,797 shares left3.7x usual sizeFiling
- 2 Form 4 sale ENTAPlan not statedJan 4, 2017 +36 days
Sold 13,921 shares at $35.09 ($488k)
Or Yat Sun, Chief Scientific Officer
Sold 4.4% of holdings ($11.1M position)301,876 shares left2.4x usual sizeFiling
- 3 Form 4 sale ENTAPlan not statedFeb 12, 2019 +769 days
Sold 33,981 shares at $89.52 ($3M)
Or Yat Sun, Sr. VP & CSO
Sold 10.1% of holdings ($30.1M position)301,916 shares leftFirst sale on recordFiling
- 4 Form 4 sale ENTAPlan not statedMar 1, 2019 +17 days
Sold 10,000 shares at $103.53 ($1M)
Or Yat Sun, Sr. VP & CSO
Sold 3.2% of holdings ($32.2M position)300,673 shares leftFiling
- 5 Form 4 sale ENTAPlan not statedMar 15, 2023 +1475 days
Sold 13,925 shares at $44.45 ($619k)
Or Yat Sun, Sr. VP & CSO
Sold 3.6% of holdings ($17.3M position)374,702 shares leftFirst sale on recordFiling
- 6 Form 4 sale ENTANo planDec 5, 2023 +265 days
Sold 2,412 shares at $9.63 ($23k)
Or Yat Sun, Sr. VP, R&D & CSO
No 10b5-1 planSold 0.6% of holdings ($3.6M position)370,695 shares leftFiling
- 7 Form 4 sale ENTARoutineDec 6, 2024 +367 days
Sold 2,591 shares at $8.06 ($21k)
Or Yat Sun, Chief Scientific Officer
10b5-1 planSold 0.7% of holdings ($3M position)369,109 shares leftFiling
- 8 Form 4 sale ENTANo planDec 5, 2025 +364 days
Sold 2,390 shares at $14.23 ($34k)
Or Yat Sun, Chief Scientific Officer
No 10b5-1 planSold 0.6% of holdings ($5.3M position)371,392 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (19)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | Dec 5, 2025 | ENTA | Chief Scientific Officer | Form 4 sale | 2,390 | $34k | 0.6% | No plan | SEC |
| Dec 6, 2024 | Dec 10, 2024 | ENTA | Chief Scientific Officer | Form 4 sale | 2,591 | $21k | 0.7% | Routine | SEC |
| Dec 5, 2023 | Dec 6, 2023 | ENTA | Sr. VP, R&D & CSO | Form 4 sale | 2,412 | $23k | 0.6% | No plan | SEC |
| Mar 15, 2023 | Mar 17, 2023 | ENTA | Sr. VP & CSO | Form 4 sale | 13,925 | $619k | 3.6% | Plan not stated | SEC |
| Mar 1, 2019 | Mar 4, 2019 | ENTA | Sr. VP & CSO | Form 4 sale | 10,000 | $1M | 3.2% | Plan not stated | SEC |
| Feb 12, 2019 | Feb 13, 2019 | ENTA | Sr. VP & CSO | Form 4 sale | 33,981 | $3M | 10.1% | Plan not stated | SEC |
| Jan 4, 2017 | Jan 5, 2017 | ENTA | Chief Scientific Officer | Form 4 sale | 13,921 | $488k | 4.4% | Plan not stated | SEC |
| Nov 29, 2016 | Nov 30, 2016 | ENTA | Chief Scientific Officer | Form 4 sale | 13,921 | $438k | 4.2% | Unusual | SEC |
| Aug 10, 2015 | Aug 11, 2015 | ENTA | Chief Scientific Officer | Form 4 sale | 3,750 | $161k | 1.8% | Plan not stated | SEC |
| Jul 13, 2015 | Jul 14, 2015 | ENTA | Chief Scientific Officer | Form 4 sale | 3,750 | $174k | 1.7% | Plan not stated | SEC |
| Jun 11, 2015 | Jun 15, 2015 | ENTA | Chief Scientific Officer | Form 4 sale | 3,750 | $159k | 1.7% | Plan not stated | SEC |
| Jun 5, 2015 | Jun 8, 2015 | ENTA | Chief Scientific Officer | Form 4 sale | 10,750 | $452k | 4.7% | Plan not stated | SEC |
| May 11, 2015 | May 12, 2015 | ENTA | Chief Scientific Officer | Form 4 sale | 8,000 | $289k | 3.4% | Plan not stated | SEC |
| Aug 13, 2014 | Aug 15, 2014 | ENTA | Chief Scientific Officer | Form 4 sale | 5,000 | $197k | 2.7% | Plan not stated | SEC |
| Jul 1, 2014 | Jul 3, 2014 | ENTA | Chief Scientific Officer | Form 4 sale | 5,000 | $211k | 2.8% | Plan not stated | SEC |
| Jun 2, 2014 | Jun 4, 2014 | ENTA | Chief Scientific Officer | Form 4 sale | 5,000 | $188k | 2.7% | Plan not stated | SEC |
| May 1, 2014 | May 2, 2014 | ENTA | Chief Scientific Officer | Form 4 sale | 5,000 | $185k | 2.6% | Plan not stated | SEC |
| Apr 1, 2014 | Apr 2, 2014 | ENTA | Chief Scientific Officer | Form 4 sale | 10,000 | $392k | 5.0% | Plan not stated | SEC |
| Mar 24, 2014 | Mar 25, 2014 | ENTA | Chief Scientific Officer | Form 4 sale | 10,000 | $393k | 4.8% | Plan not stated | SEC |